Expiry of nine Quetiapine SSPs (SSP062-SSP070)

The Department of Health and Social Care (DHSC) has confirmed that sufficient stock of Quetiapine tablets is now available to meet normal demand. As a result the following  Serious Shortage Protocols, will expire at 23.59pm on Friday 13 September 2024. After this date, any prescriptions for Quetiapine tablets must be dispensed in accordance with the prescription, and the SSPs will no longer be valid for use.

Top tips for SSP claims

• Where available, use the claim amend facility on the PMR system to rectify any incorrect EPS claims already submitted this month.
• Any paper prescriptions with SSP claims need to be placed in the red separator provided by the NHSBSA.
• For any supplies made in accordance with SSPs, check that the correct number of patient charges are collected and declared on the end of month FP34C submission document.
• Although an SSP cannot be used outside its period of validity, claims can be submitted up to three calendar months after expiry or withdrawal of the SSP to help manage any owings for other items issued on the same prescription form. For example, for SSP062 Quetiapine 150mg tablets substitution, which expires at 23.59pm on Friday 13 September 2024, the NHSBSA would continue to look for the “SSP” endorsement on prescriptions for Quetiapine 150mg tablets that are submitted with the September batch (submitted by 5 October), October batch (submitted by 5 November) and November batch (submitted by 5 December).
• NHSBSA advise that contractors must follow the specific endorsement guidance issued with each SSP and endorsements should be clear and unambiguous – NHSBSA processing staff must be able to determine what has been supplied.
• Pharmacy contractors should keep a record of all SSP claims submitted each month to reconcile against their monthly Schedule of Payments or Prescription Item (Px) reports.
• View our SSP submission guidance to ensure your SSP claims are appropriately submitted to NHSBSA  for reimbursement.

Community Pharmacy England previously reported that the NHS Business Services Authority (NHSBSA) received a number of EPS SSP claims which did not meet the requirements for a valid SSP claim. A large number SSP claims continue to be deemed invalid by the NHSBSA due to incorrect endorsements applied by PMR systems and/or pharmacy staff. We recommend pharmacy owners to regularly reconcile the value of SSP fees on their payment schedules against the number of SSPs declared on the FP34C submission form. Please refer to our new guidance on reconciliation of SSP claims.

If there is a payment discrepancy and it is believed that the correct SSP endorsing guidance was followed, pharmacy owners may consider requesting a re-check of relevant prescriptions and the NHSBSA will be able to explain why the claim was unpaid or rectify the payments.

Pharmacy teams are reminded to follow the SSP-specific guidance to ensure endorsements are applied correctly, and we also have guidance supporting teams raising PMR-specific claiming issues with their suppliers.

Additional information

Serious Shortage Protocols (SSPs)

Briefing 011/21: Serious Shortage Protocols (SSPs) updated endorsing guidance

CPE’s SSP FAQ page

NHSBSA SSP page